Therabron Therapeutics Completes Enrollment of Phase 2 Clinical Trial for Lead Product Candidate CG100 for the Prevention of Chronic Lung Disease in Preterm Infants

ROCKVILLE, MD, May 25, 2016 — Therabron Therapeutics, Inc., a clinical-stage biotechnology company dedicated to advancing a new standard in respiratory care, today announced the Company has completed enrollment of its […]

By |May 25th, 2016|Uncategorized|

Therabron Therapeutics Receives FDA Fast Track Designation for rhCC10 for the Prevention of Chronic Lung Disease Related to Premature Birth

ROCKVILLE, MD, April 28, 2016 — Therabron Therapeutics, Inc., a clinical-stage biotechnology company dedicated to advancing a new standard in respiratory care, announced today that it has received Fast Track Designation […]

By |April 28th, 2016|Uncategorized|

Therabron Therapeutics to Present at World Orphan Drug Congress USA 2016

ROCKVILLE, MD, April 19, 2016 — Therabron Therapeutics, Inc., a clinical-stage biotechnology company dedicated to advancing a new standard in respiratory care, today announced that Dr. Thomas F. Miller, President […]

By |April 20th, 2016|Uncategorized|

Therabron Therapeutics to Present at the 2016 Biotech Showcase Conference

ROCKVILLE, MD, January 7, 2016 – Therabron Therapeutics, Inc., a specialty biotechnology company dedicated to redefining the management of respiratory disease through innovation, today announced that its President and Chief Executive Officer, […]

By |January 7th, 2016|Uncategorized|